AUTOIMMUNITY part 68

Immune 4

 

Anti-T-Lymphocyte Therapy

T cells play a key role in the pathogenesis of type IV autoimmune reactions and also are critical for generating the T-cell-dependent autoantibodies mediating type II and type III autoimmune diseases. Consequently, considerable effort has gone into the development of therapeutic agents that selectively or nonselectively target T lymphocytes. Drugs that target primarily T cells include cyclophosphamide, azathioprine, cyclosporin A, tacrolimus and the biological CTLA4-Ig. Cyclophosphamide  is an alkylating agent that substitutes alkyl radicals into DNA and RNA. The drug is inactive by itself but is converted to an active metabolite responsible for its immunosuppressive effects. It is used for the treatment  of lupus nephritis and other life-threathening complications of SLE and other systemic autoimmune diseases.

Advertisements

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s